VivAer® Stylus Treatment for nasal obstruction
Nasal Airflow Resistance
- Nasal valve area is the narrowest region of nasal airway⁶
- Most common site of nasal airway obstruction⁶
- Accounts for 2/3 of nasal resistance⁶
Small changes make large improvements to
Bernoulli’s Principle: Increase in airflow velocity leads to a decrease in pressure
Poiseuille’s Law: Airflow is proportional to the 4th power of the change in radius
VivAer Stylus: Comprehensive treatment
Treating anterior anatomy to open the nasal airway
- Durably remodels soft tissue, including cartilage, in the nasal valve
- Increases the radius of the nasal valve to improve breathing
- Shrinks submucosal tissue of the inferior Turbinate
- Reduces soft tissue obstruction on the septum
- Treatment does not alter patient aesthetics
Clinically proven durable results
and high patient satisfaction
Statistically significant improvement shown in prospective, multicenter study:³
- 89% report improved sleep quality
- 94% report improved ability to breathe through their nose during exercise or exertion
Which patients can benefit most from this procedure?
- Patients who have a NOSE score >60 and experience improvement with the modified Cottle’s maneuver
- Postsurgical patients who have undergone nasal obstruction surgery and still have difficulty breathing
- Surgically naïve patients who wish to avoid traditional surgery and a lengthy recovery
- Adjunct to surgery patients who are candidates for traditional surgery (e.g., septum, turbinates) and respond well to modified Cottle’s maneuver
Ready to adopt Aerin into your practice?
The Aerin™ System fits seamlessly into the office or OR enviroment. Many payers have coverage policies in place for the treatment of nasal airway obstruction or chonic rhinitis. To learn more, contact Aerin Medical at (833)-484-8237
⁷ Data on file. Aerin Medical, Report TR470.
⁶ Clin. Otolaryngol. 1997, 22, 307-317; REVIEW Acoustic rhinometry; E.W.FISHER; ENT Department, Birmingham Heartlands Hosptal, Birmingham, UK.weeks.
³ Data on file with Aerin Medical, Report TR680-01.